다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기
Journal of Korean medical science : JKMS, v.20 no.4 = no.104, 2005년, pp.643 - 648
Kim, Mi Jin (Department of Pathology, College of Medicine, Yeungnam University, Daegu, Korea.)
AI-Helper
Distinguishing primary ovarian carcinoma from metastatic carcinoma to the ovary is often difficult by histologic examination alone. Recently an immunohistochemical marker CDX-2 was found to be of considerable diagnostic value in establishing the gastrointestinal origin of metastatic tumors. The aim ...
1 Scully RE Young RH Philip BC Atlas of tumor pathology: Tumors of the ovary, maldeveloped gonads, fallopian tube, and broad ligament 1998 Washington D.C AFIP 3rd series
2 Daya D Nazerali L Frank GL Metastatic ovarian carcinoma of large intestinal origin simulating primary ovarian carcinoma. A clinicopathologic study of 25 cases Am J Clin Pathol 1992 97 751 758 1595595
3 Ueda G Sawada M Ogawa H Tanizawa O Tsujimoto M Immunohistochemical study of cytokeratin-7 for the differential diagnosis of adenocarcinomas in the ovary Gynecol Oncol 1993 51 219 223 7506222
4 Loy TS Calaluce RD Keeney GL Cytokeratin immunostaining in differentiating primary ovarian carcinoma from metastatic colonic adenocarcinoma Mod Pathol 1996 9 1040 1044 8933513
5 Berezowski K Stastny JF Kornstein MJ Cytokeratin 7 and 20 and carcinoembryonic antigen in ovarian and colonic carcinoma Mod Pathol 1996 9 426 429 8729984
6 Fowler LJ Maygarden SJ Novotny DB Human alveolar macrophage-56 and carcinoembryonic antigen monoclonal antibdies in the differential diagnosis between primary ovarian and metastatic gastrointestinal carcinomas Hum Pathol 1994 25 666 670 8026826
7 Albarracin CT Jafri J Montag AG Hart J Kuan SF Differential expression of MUC2 and MUC5AC mucin genes in primary ovarian and metastatic colonic carcinoma Hum Pathol 2000 31 672 677 10872659
8 Suh E Traber PG An intestine-specific homeobox gene regulates proliferation and differentiation Mol Cell Biol 1996 16 619 625 8552090
9 Seno H Oshima M Taniguchi MA Usami K Ishikawa TO Chiba T Taketo MM CDX2 expression in the stomach with intestinal metaplasia and intestinal-type cancer: prognostic implications Int J Oncol 2002 21 769 774 12239615
10 Werling RW Yaziji H Bacchi CE Gown AM CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas Am J Surg Pathol 2003 27 303 310 12604886
11 Lee KR Young RH The distinction between primary and metastatic mucinous carcinomas of the ovary: gross and histologic findings in 50 cases Am J Surg Pathol 2003 27 281 292 12604884
12 Kononen J Bubendorf L Kallioniemi A Barlund M Schraml P Leighton S Torhorst J Mihatsch MJ Sauter G Kallioniemi OP Tissue microarrays for high-throughput molecular profiling of tumor specimens Nat Med 1998 4 844 847 9662379
13 Bai YQ Yamamoto H Akiyama Y Tanaka H Takizawa T Kake M Kenji Yagi O Saitoh K Takeshita K Iwai T Yuasa Y Ectopic expression of homeodomain protein CDX2 in intestinal metaplasia and carcinomas of the stomach Cancer Lett 2002 176 47 55 11790453
14 Li MK Folpe AL CDX-2, a new marker for adenocarcinom of gastrointestinal origin Adv Anat Pathol 2004 11 101 105 15090846
15 Eda A Osawa H Yanaka I Satoh K Mutoh H Kihira K Sugano K Expression of homeobox gene CDX2 precedes that of CDX1 during the progression of intestinal metaplasia J Gastroenterol 2002 37 94 100 11871772
16 Vassil K Luig T Luig T The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas Mod Pathol 2004 17 1392 1399 15205684
17 Groisman GM Meir A Sabo E The value of CDX2 immunostaining in differentiating primary ovarian carcinomas from colonic carcinomas metastatic to the ovaries Int J Gynecol Pathol 2004 23 52 57 14668551
18 Logani S Oliva E Arnell PM Amin MB Young RH Use of novel immunohistochemical markers expressed in colonic adenocarcinoma to distinguish primary ovarian tumors from metastatic colorectal carcinoma Mod Pathol 2005 18 19 25 15389251
19 Fraggetta F Peloci G Cafici A Nuciforo P Viale G CDX2 immunoreactivity in primary and metastatic ovarian mucinous tumors Virchows Arch 2003 443 782 786 14576939
20 Kaimaktchieve V Terracciano L Tornillo L Spichtin H Stoios D Bundi M Korcheva V Mirlacher M Loda M Sauter G Corless CL The homeobox intestinal differentiation factor CDX 2 is selectively expressed in gastrointestinal adenocarcinomas Mod Pathol 2004 17 1392 1399 15205684
21 Barbareschi M Murer B Colby TV Chilosi M Macri E Loda M Doglioni C CDX-2 homeobox gene expression is a reliable marker of colorectal adenocarcinoma metastatses to the lungs Am J Surg Pathol 2003 27 141 149 12548159
22 Raspollini MR Baroni G Taddei A Taddei GL Primary cervical adenocarcinoma with intestinal differentiation and colonic carcinoma metastatic to cervix. An investigation using CDX-2 and a limited immunohistochemical panel Arch Pathol Lab Med 2003 127 1586 1590 14632574
23 Franchi A Massi D Palomba A Biancalani M Santucci M CDX-2, cytokeratin 7 and cytokeratin 20 immunohistochemical expression in the differential diagnosis of primary adenocarcinomas of the sinonasal tract Virchows Arch 2004 445 63 67 15175880
24 McCluggage WG Recent advances in immunohistochemistry in the diagnosis of ovarian neoplasm J Clin Pathol 2000 53 327 334 10889812
25 Lagendijk JH Mullink H Van Diest PJ Meijer GA Meijer CJ Tracing the origin of adenocarcinomas with unknown primary using immunohistochemistry: differential diagnosis between colonic and ovarian carcinomas as primary sites Hum Pathol 1998 29 491 497 9596273
26 Wauters CC Smedts F Gerrits LG Bosman FT Ramaekers FC Keratins 7 and 20 as a dignostic markers of carcinomas metastatic to the ovary Hum Pathol 1995 26 852 855 7543441
27 Lash RH Hart WR Intestinal adenocarcinomas metastatic to the ovaries. A clinicopathologic evaluation of 22 cases Am J Surg Pathol 1987 11 114 121 3812871
28 Lagendijk JH Mullink H van Diest PJ Meijer GA Meijer CJ Immunohistochemical differentiation between primary adenocarcinomas of the ovary and ovarian metastases of colonic and breast origin. Comparison between a statistical and an intuitive approach J Clin Pathol 1999 52 283 290 10474521
29 Cirisano FD Karlan BY The role of the HER-2/neu oncogene in gynecologic cancers J Soc Gynecol Invest 1996 3 99 105
30 Iwamoto H Fukasawa H Honda T Hirata S Hoshi K HER-2/neu expression in ovarian clear cell carcinomas Int J Gynecol Cancer 2003 13 28 31 12631216
Copyright KISTI. All Rights Reserved.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.